9 August 2019
Pharmaceutics Reaches 1000 Article Milestone
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Pharmaceutics, MDPI’s open-access journal on the science and technology of pharmaceutics and biopharmaceutics, has published more than 1000 articles and reviews since its inception in 2009. Pharmaceutics is now indexed by Science Citation Index Expanded (Web of Science) (Impact Factor 4.773, ranks 26/267 (Q1) in the category “Pharmacology & Pharmacy” in the Journal Citation Reports), PubMed, and Scopus. It is also a member of DOAJ.
Our sincerest thanks go to the Editor-in-Chief of Pharmaceutics, Prof. Dr. Yvonne Perrie, and all the Editorial Board members, as well as to Guest Editors of Special Issues. Only with their strong support can we achieve rapid growth in publications and maintain our high level of quality.